Most Recent
A judge overseeing four COVID-19 business interruption class actions has questioned a decision by insurers to use ten test cases to resolve the issue of whether they had to indemnify policyholders instead of a class action, which would have been binding.
A judge has ordered Meta to pay a $20 million penalty for misleading consumers by representing that its discontinued Onavo Protect mobile app would keep users’ personal activity data private, when in fact it was being collected for commercial use.
An appeals court has taken Pitcher Partners to task in its appeal seeking to throw out a lawsuit over the accounting firm’s alleged involvement in race car driver Max Twigg’s misappropriation of $127 million from his family.
Commonwealth Bank and other lenders of Arrium have filed for special leave to appeal to the High Court after losing their latest bid to make two directors liable for allegedly misleading them about loan drawdown notices ahead of the steel company's $2.8 billion collapse.
Shine Lawyers’ bid to recoup "exorbitant" interest on a loan it took out to run pelvic mesh class actions against Johnson & Johnson has raised new ethical dilemmas beyond the usual "sweaty palms and huge vexation" in most group proceedings, a judge has said.
A judge has ordered the owner of vitamin brand Life Botanics to refrain from “vilifying, denigrating, disparaging or mocking” rival JSHealth, owned by influencer Jessica Sepel.
Seven Network and law firms Herbert Smith Freehills and Addisons are fighting Fairfax’s bid for communications relating to Ben Roberts-Smith’s unsuccessful defamation case, as the publisher seeks its significant defence costs.
A PricewaterhouseCoopers partner who is suing the accounting firm for giving him the boot over a tax leaks scandal has won an interim injunction restraining the board of partners from forcing him to leave before his case is heard.
A judge has upheld findings from IP Australia that South Korean biotech ToolGen's genome editing technology CRISPR is not patentable, but given the company one more chance to seek to amend its application.